Interview with CEO Linda Persson from Dirket Studios
In todayโs broadcast from Dirket Studios, NanoEcho’s CEO, Linda Persson, participated. During the interview, Linda discusses the recently completed equity issue, this week’s listing on Nasdaq First North Growth Market, and NanoEcho’s future focus areas. Watch the full interview in Swedish here ๐
Listing on Nasdaq First North Growth Market
August 6 marks a significant milestone for NanoEcho! We are now listed on Nasdaq First North Growth Market. We are incredibly proud of the hard work that has made this possible. A big thank you to all the investors who have continued to trust us, and a warm welcome to all new investors to NanoEcho! […]
The development of the NanoEcho imaging device completed and ready for clinical studies
Today, the formal verification has been successfully completed without any remarks, which is the final step in product development. The system now meets the requirements of customers and authorities for medical devices. This means that NanoEcho’s commercial imaging system is fully developed and ready to be used on patients in clinical studies. “This is a […]
Affรคrsvรคrlden highlights NanoEcho in an article
NanoEcho is featured in an article published by Affรคrsvรคrlden! In the interview with Linda Persson, you can read about NanoEcho and the ongoing emission. ‘Our technology has several advantages. We address an issue with inadequate diagnostics, which means less suffering for the patient and lower costs for healthcare,’ says Linda Persson. Read the full article […]
Watch our live company presentation with NanoEcho’s CEO
Did you miss our live company presentation with NanoEcho’s CEO, Linda Persson, yesterday? No worries, you can watch it afterwards. The presentation is now also subtitled. NanoEcho is currently conducting a new share issue to enter the clinical phase with our patented diagnostic method. The goal is to improve healthcare by providing patients with rectal […]
NanoEcho invites you to a live company presentation
On Monday, June 10 at 5:00 PM, NanoEcho invites you to a live company presentation in light of the ongoing share issue. The presentation will be conducted by our CEO, Linda Persson. This is an excellent opportunity to get to know NanoEcho and our efforts to provide future healthcare with more precise, simple, and cost-effective […]
Finwire Media publishes presentation of NanoEcho ahead of IPO
Ahead of the upcoming stock exchange listing, Finwire Media has published a presentation where our CEO, Linda Persson, discusses NanoEcho’s technology with the aim of improving the diagnosis of rectal cancer and creating significant health-economic benefits for society. Linda also shares her insights on the company’s strategy to get the system approved and implemented as […]
Interview with CEO, Linda Persson, in Privata Affรคrer
๐๐จ ๐ฒ๐จ๐ฎ ๐ฐ๐๐ง๐ญ ๐ญ๐จ ๐ค๐ง๐จ๐ฐ ๐ฆ๐จ๐ซ๐ ๐๐๐จ๐ฎ๐ญ ๐๐๐ง๐จ๐๐๐ก๐จโ๐ฌ ๐ข๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐ฏ๐ ๐๐ข๐๐ ๐ง๐จ๐ฌ๐ญ๐ข๐ ๐ฆ๐๐ญ๐ก๐จ๐ ๐๐ง๐ ๐ญ๐ก๐ ๐จ๐ง๐ ๐จ๐ข๐ง๐ ๐ฌ๐ก๐๐ซ๐ ๐ข๐ฌ๐ฌ๐ฎ๐? Don’t miss the interview with our CEO, Linda Persson, in Privata Affรคrer. NanoEcho is currently conducting a new share issue to enter the clinical phase with our patented diagnostic method, which aims to improve healthcare by providing patients with […]
An inspiring Saturday with a goal-oriented team!
Today NanoEcho run the Lundaloppet together through a flourishing Lund โ and what fantastic performances! Combining health with team building is a powerful union for promoting collaboration and well-being. Prioritising health not only provides physical benefits but also increases energy levels and improves focus and performance at work. An inspiring Saturday with a goal-oriented team!
CEO Linda Persson summarises the first quarter of 2024
Don’t miss when CEO Linda Persson summarises the first quarter of 2024 in conjunction with the published quarterly report. We can confirm that NanoEcho once again leaves behind an eventful quarter, during which we have successfully reached several important milestones. “During this quarter, we have achieved significant milestones in our efforts to improve rectal cancer […]
